OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden

K.l. Grøn; E. Arkema; B. Glintborg; F. Mehnert; M. Østergaard; L. Dreyer; M. Nørgaard; N.s. Krogh; J. Askling; M. Heltand

doi:10.1136/annrheumdis-2018-eular.2389

OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden

K.l. Grøn, E. Arkema, B. Glintborg, F. Mehnert, M. Østergaard, L. Dreyer, M. Nørgaard, N.s. Krogh, J. Askling, M. Heltand

Original language	English
Publication date	2018
Number of pages	1
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.2389
Publication status	Published - 2018

Access to Document

10.1136/annrheumdis-2018-eular.2389

208.1.full.pdfFinal published version, 487 KB

Cite this

@conference{3d0cd90a341143b39676bce1f471bb10,

title = "OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden",

author = "K.l. Gr{\o}n and E. Arkema and B. Glintborg and F. Mehnert and M. {\O}stergaard and L. Dreyer and M. N{\o}rgaard and N.s. Krogh and J. Askling and M. Heltand",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.2389",

language = "English",

pages = "208--208",

}

TY - ABST

T1 - OP0324 Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in denmark and sweden

AU - Grøn, K.l.

AU - Arkema, E.

AU - Glintborg, B.

AU - Mehnert, F.

AU - Østergaard, M.

AU - Dreyer, L.

AU - Nørgaard, M.

AU - Krogh, N.s.

AU - Askling, J.

AU - Heltand, M.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.2389

DO - 10.1136/annrheumdis-2018-eular.2389

M3 - Conference abstract for conference

SP - 208

EP - 208

ER -